Enanta Pharmaceuticals Company Profile, Contacts & Intelligence

Enanta Pharmaceuticals Overview

Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs with an emphasis on indications in virology and immunology. Enanta’s clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting key drivers of the type 2 immune response, including KIT and STAT6 inhibition. Glecaprevir, a protease inhibitor discovered by Enanta, is part of one of the leading treatment regimens for curing chronic and acute hepatitis C virus (HCV) infection and is sold by AbbVie in numerous countries under the tradenames MAVYRET® (U.S.) and MAVIRET® (ex-U.S.) (glecaprevir/pibrentasvir). A portion of Enanta’s royalties from HCV products developed under its collaboration with AbbVie contribute ongoing funding to Enanta’s operations. Please visit www.enanta.com for more information.

Headquarters

Watertown, Ma, United States

Website

enanta.com

Industry

Biotechnology Research

Founded

1995

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Phone Number

Available in AeroLeads

Company Email

Available in AeroLeads

Enanta Pharmaceuticals Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Enanta Pharmaceuticals People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Enanta Pharmaceuticals Workforce Composition

Seniority breakdown across 22 visible profiles.

Enanta Pharmaceuticals Technology & Talent

Technology-related job titles represented in the visible people data.

Compare Similar Companies to Enanta Pharmaceuticals

Explore companies in related markets and compare their industry and employee estimates.